GCAR-GBM-AGILE
Phase II/III
OPEN TO ACCRUAL
GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM)
IIT-SCHMAINDA-RCBV
Phase N/A
OPEN TO ACCRUAL
Magnetic Resonance Imaging (MRI) Contrast Methods to Assess Tumor Angiogenesis